NASDAQ
7.94USD
-0.05 (-0.63%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
288.5M
P/E
—
EPS
—
Beta
0.53
52W range
3.76-8.95
Day range
7.64–8.09
Open
7.84
Prev close
7.99
Volume
85.3K
Avg volume
73.7K
Dividend
0.00
IPO
2019-10-29
https://www.zacks.com/stock/news/2970648/profound-medical-prof-q2-earnings-surpass-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2970648 · 8/7/2026+0.30
https://www.globenewswire.com/news-release/2026/07/15/3327615/33471/en/Profound-Medical-Autonomous-Robotics-and-Incisionless-Surgery-to-Have-Exceptional-Presence-at-SRS2026.html · 7/15/2026+0.80
https://www.zacks.com/stock/news/2949152/profound-medical-prof-moves-8-2-higher-will-this-strength-last?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|daily_price_change_5%-2949152 · 7/7/2026+0.60
https://www.zacks.com/stock/news/2890113/profound-medical-prof-surges-13-0-is-this-an-indication-of-further-gains?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|daily_price_change_5%-2890113 · 3/26/2026+0.60
https://www.benzinga.com/trading-ideas/long-ideas/26/03/51373991/top-3-health-care-stocks-that-are-set-to-fly-in-march · 3/20/2026+0.50
https://www.zacks.com/stock/news/2790887/profound-medical-prof-reports-q3-loss-tops-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2790887 · 11/13/2025+0.40
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
